Vasacad-S (Sacubritil + Valsartan)
Sacubitril + Valsartan is a combination therapy for treating chronic heart failure in adults and children over one year old, combining neprilysin inhibition and angiotensin II receptor blocking to improve heart function and reduce hospitalizations.
- The description claims improved outcomes compared to conventional ACE-inhibitor therapy.
- The description claims synergistic action between Sacubitril and Valsartan.
Specifications
- Form & Size
- Film Coated Tablet 50 (24 + 26 mg) in Box of 30's, Film Coated Tablet 100 (49 + 51 mg) in Box of 30's, Film Coated Tablet 200 (97 + 103 mg) in Box of 30's
Variants (3)
- Film Coated Tablet 50 (24 + 26 mg) in Box of 30's — 2610.00 PHP — In stock
- Film Coated Tablet 100 (49 + 51 mg) in Box of 30's — 2610.00 PHP — In stock
- Film Coated Tablet 200 (97 + 103 mg) in Box of 30's — 2610.00 PHP — In stock
AI Readiness
Good foundation, but some important product data is still missing.
74%